Abstract
We identify three submicromolar inhibitors with new chemical scaffolds for cystathionine γ-lyase (CSE) by a tandem-well-based high-throughput assay. NSC4056, the most potent inhibitor with an IC50 of 0.6 μM, which is also known as aurintricarboxylic acid, selectively binds to Arg and Tyr residues of CSE active site and preferably inhibits the CSE activity in cells rather than cystathionine β-synthase (CBS), the other H2S-generating enzyme. Moreover, NSC4056 effectively rescues hypotension in hemorrhagic shock rats.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Aurintricarboxylic Acid / chemistry
-
Aurintricarboxylic Acid / metabolism
-
Aurintricarboxylic Acid / pharmacology*
-
Catalytic Domain / drug effects
-
Cystathionine gamma-Lyase / antagonists & inhibitors*
-
Cystathionine gamma-Lyase / chemistry
-
Cystathionine gamma-Lyase / metabolism
-
Drug Discovery
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology*
-
HEK293 Cells
-
Humans
-
Male
-
Mice
-
Molecular Docking Simulation
-
Molecular Structure
-
Nitroquinolines / pharmacology
-
Protein Binding
-
RAW 264.7 Cells
-
Rats, Sprague-Dawley
-
Structure-Activity Relationship
Substances
-
Enzyme Inhibitors
-
Nitroquinolines
-
Aurintricarboxylic Acid
-
nitroxoline
-
Cystathionine gamma-Lyase